These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37965961)

  • 1. Microvascular dysfunction in hypertrophic cardiomyopathy: diagnostic role of noninvasive, fully automated quantitative perfusion cardiovascular magnetic resonance imaging.
    Borodzicz-Jazdzyk S; de Mooij GW; van Loon RB; Götte MJW
    Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 37965961
    [No Abstract]   [Full Text] [Related]  

  • 2. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial stress perfusion magnetic resonance in children with hypertrophic cardiomyopathy.
    Hernandez LE
    Cardiol Young; 2018 May; 28(5):702-708. PubMed ID: 29467047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance for screening in hypertrophic cardiomyopathy: the new family plan.
    Rowin EJ; Maron MS
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1155-1156. PubMed ID: 35796102
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
    Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
    J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
    Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part I].
    Pleva M; Borová J; Plevová I; Januška J; Belicová M
    Vnitr Lek; 2017; 63(3):194-198. PubMed ID: 28379022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on the application of cardiovascular magnetic resonance in the diagnosis of hypertrophic cardiomyopathy].
    Yu SQ; Zhao SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jun; 47(6):508-512. PubMed ID: 31262141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction as assessed by multimodal diagnostic imaging in patients with hypertrophic cardiomyopathy is related to the severity of cardiac dysfunction.
    Tran TV; Djaileb L; Riou L; Lantuejoul LR; Giai J; Barone-Rochette G
    Microcirculation; 2024 Feb; 31(2):e12843. PubMed ID: 38174616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
    Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular dysfunction in hypertrophic cardiomyopathy evaluated by cardiac magnetic resonance and computed tomography.
    Moral S; Fernandez-Friera L; Sanz J
    Acta Cardiol; 2010 Jun; 65(3):367-9. PubMed ID: 20666282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part II].
    Pleva M; Borová J; Plevová I; Januška J; Belicová M
    Vnitr Lek; 2017; 63(4):249-253. PubMed ID: 28520448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy.
    Hughes RK; Augusto JB; Knott K; Davies R; Shiwani H; Seraphim A; Malcolmson JW; Khoury S; Joy G; Mohiddin S; Lopes LR; McKenna WJ; Kellman P; Xue H; Tome M; Sharma S; Captur G; Moon JC
    Circ Cardiovasc Imaging; 2023 Mar; 16(3):e014907. PubMed ID: 36943913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy.
    Ku MC; Kober F; Lai YC; Pohlmann A; Qadri F; Bader M; Carrier L; Niendorf T
    J Cardiovasc Magn Reson; 2021 May; 23(1):63. PubMed ID: 34053450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy: when is it superior to echocardiography?].
    Kammoun I; Marrakchi S; Zidi A; Ibn ElHaj Z; Naccache S; Ben Amara W; Jebri F; Bennour E; Kachboura S
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):9-13. PubMed ID: 24834991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary microvascular dysfunction in hypertrophic cardiomyopathy detected by Rubidium-82 positron emission tomography and cardiac magnetic resonance imaging.
    Moody WE; Schmitt M; Arumugam P
    J Nucl Cardiol; 2019 Apr; 26(2):666-670. PubMed ID: 29516367
    [No Abstract]   [Full Text] [Related]  

  • 19. Robust semi-automated quantification of cardiac MR perfusion using level set: Application to hypertrophic cardiomyopathy patient data.
    Kim YC; Kim SM; Choe YH
    Comput Biol Med; 2016 Apr; 71():162-73. PubMed ID: 26945464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion CMR and SPECT in hypertrophic cardiomyopathy.
    O'Hanlon R; Teo K; Bucciarelli-Ducci C; Pennell DJ
    Int J Cardiol; 2008 Sep; 129(1):e27-9. PubMed ID: 17706805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.